VX-814

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-814, covering 2022-02-02 to 2022-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype [Phase 2]